[{"address1": "One Design Center Place", "address2": "Suite 17- 500", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 520 9158", "website": "https://www.entradatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV\u0099)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programmes for the potential treatment of neuromuscular and ocular diseases, among others. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 183, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dipal  Doshi", "age": 49, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 959310, "exercisedValue": 0, "unexercisedValue": 12719836}, {"maxAge": 1, "name": "Mr. Nathan J. Dowden", "age": 54, "title": "President & COO", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 709810, "exercisedValue": 0, "unexercisedValue": 2894005}, {"maxAge": 1, "name": "Dr. Natarajan  Sethuraman Ph.D.", "age": 63, "title": "President of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 727192, "exercisedValue": 0, "unexercisedValue": 2532836}, {"maxAge": 1, "name": "Mr. Kory James Wentworth CPA", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jared  Cohen J.D., Ph.D.", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karla  MacDonald", "title": "Chief Corporate Affairs Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Healy Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sandeep  Basnet", "title": "Head of Information Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.28, "open": 10.25, "dayLow": 9.84, "dayHigh": 10.36, "regularMarketPreviousClose": 10.28, "regularMarketOpen": 10.25, "regularMarketDayLow": 9.84, "regularMarketDayHigh": 10.36, "payoutRatio": 0.0, "beta": -0.124, "forwardPE": -2.5109308, "volume": 214724, "regularMarketVolume": 214724, "averageVolume": 222522, "averageVolume10days": 175410, "averageDailyVolume10Day": 175410, "bid": 8.1, "ask": 11.21, "bidSize": 2, "askSize": 1, "marketCap": 384103296, "fiftyTwoWeekLow": 4.93, "fiftyTwoWeekHigh": 18.75, "allTimeHigh": 36.85, "allTimeLow": 4.93, "priceToSalesTrailing12Months": 6.2435517, "fiftyDayAverage": 9.1634, "twoHundredDayAverage": 7.569225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 85970648, "profitMargins": -1.6816499, "floatShares": 17473902, "sharesOutstanding": 38219232, "sharesShort": 898798, "sharesShortPriorMonth": 926483, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0235, "heldPercentInsiders": 0.12239, "heldPercentInstitutions": 0.78376, "shortRatio": 4.11, "shortPercentOfFloat": 0.0432, "impliedSharesOutstanding": 38219232, "bookValue": 9.501, "priceToBook": 1.0577834, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -103455000, "trailingEps": -2.57, "forwardEps": -4.0025, "enterpriseToRevenue": 1.397, "enterpriseToEbitda": -0.733, "52WeekChange": -0.44321328, "SandP52WeekChange": 0.14778805, "quoteType": "EQUITY", "currentPrice": 10.05, "targetHighPrice": 20.0, "targetLowPrice": 13.0, "targetMeanPrice": 16.5, "targetMedianPrice": 16.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 326838016, "totalCashPerShare": 9.114, "ebitda": -117355000, "totalDebt": 52400000, "quickRatio": 13.741, "currentRatio": 14.083, "totalRevenue": 61520000, "debtToEquity": 15.379, "revenuePerShare": 1.494, "returnOnAssets": -0.15705, "returnOnEquity": -0.27111998, "grossProfits": -80198000, "freeCashflow": -92327128, "operatingCashflow": -127914000, "revenueGrowth": -0.918, "grossMargins": -1.30361, "ebitdaMargins": -1.90759, "operatingMargins": -29.1518, "financialCurrency": "USD", "symbol": "TRDA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Entrada Therapeutics, Inc.", "longName": "Entrada Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1767388204, "regularMarketTime": 1767387600, "exchange": "NGM", "messageBoardId": "finmb_595472652", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.23735, "regularMarketPrice": 10.05, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1635514200000, "postMarketChangePercent": 0.0, "postMarketPrice": 10.05, "postMarketChange": 0.0, "regularMarketChange": -0.23, "regularMarketDayRange": "9.84 - 10.36", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 222522, "marketState": "CLOSED", "fiftyTwoWeekLowChange": 5.1200004, "fiftyTwoWeekLowChangePercent": 1.0385396, "fiftyTwoWeekRange": "4.93 - 18.75", "fiftyTwoWeekHighChange": -8.7, "fiftyTwoWeekHighChangePercent": -0.464, "fiftyTwoWeekChangePercent": -44.321327, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.57, "epsForward": -4.0025, "epsCurrentYear": -3.3675, "priceEpsCurrentYear": -2.9844098, "fiftyDayAverageChange": 0.8866005, "fiftyDayAverageChangePercent": 0.096754536, "twoHundredDayAverageChange": 2.4807754, "twoHundredDayAverageChangePercent": 0.32774496, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-29", "cryptoTradeable": false, "displayName": "Entrada Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]